Over the last 180 days, Xilio Therapeutics, Inc. insiders bought a net $43.9K of stock across 26 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.
Showing the most recent few. Create a free account to see 21 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $43.8M | $6.3M | — | — |
| OPERATING INCOME | $-42.0M | $-60.6M | $-79.1M | $-89.1M |
| NET INCOME | $-35.0M | $-58.2M | $-76.4M | $-88.2M |
| EPS (DILUTED) | -4.19 | -15.24 | -2.78 | -3.22 |
| OPERATING CASH FLOW | $-5.0M | $-18.4M | $-68.6M | $-75.7M |
| CASH | $137.5M | $55.3M | $44.7M | $120.4M |
No password to create and no card required. We store your email address and nothing else.